Mesothelioma Treatment: A Brief Overview

Mesothelioma is a rare, aggressive cancer caused primarily by asbestos exposure, affecting the lining of the lungs, abdomen, heart, or testes. Due to

Mesothelioma is a rare, aggressive cancer caused primarily by asbestos exposure, affecting the lining of the lungs, abdomen, heart, or testes. Due to its late diagnosis and resistance to conventional therapies, treating mesothelioma presents significant challenges. However, a combination of surgery, chemotherapy, radiation therapy, and emerging treatments offers hope for patients.

Surgery is often the first line of treatment, especially for early-stage mesothelioma. Procedures like Extrapleural Pneumonectomy (EPP) and **Pleurectomy/Decortication (P/D)** aim to remove tumors and surrounding tissues. For peritoneal mesothelioma, **Cytoreductive Surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)** is particularly effective.

Chemotherapy is commonly used to shrink tumors and control the spread of cancer. The combination of Pemetrexed and Cisplatin is the standard regimen, offering the best outcomes when surgery isn’t feasible. Radiation therapy, including **External Beam Radiation Therapy (EBRT)**, helps control local tumors and alleviate symptoms.

Emerging treatments, like Immunotherapy and  Targeted Therapy , are at the forefront of mesothelioma research. These therapies harness the body’s immune system or target specific cancer cell mechanisms, showing promise in clinical trials. **Photodynamic Therapy (PDT)** is another innovative approach, using light-sensitive drugs to kill cancer cells during surgery.

A multidisciplinary approach is essential for managing mesothelioma, involving surgeons, oncologists, and palliative care specialists to tailor treatment to each patient’s needs. Despite the challenges, ongoing research and new therapies offer hope, improving survival rates and quality of life for those affected by this devastating disease.